史蒂文斯-约翰逊综合征的病例报告是由梅所引起的
Yuanhang Xu1, Lingjuan Zhang, Lin Shen
1Department of Gastroenterology, Shaanxi Provincial People's Hospital, Xi'an, China.
Medicine
|September 10, 2024
概括
本病例报告详细介绍了一名患有慢性急性肝衰竭的患者,在使用梅后患上了史蒂文斯-约翰逊综合征 (SJS). 及时治疗导致症状缓解,肝脏和脏功能得到改善,突出显示SJS在复杂肝脏疾病中的管理.
科学领域:
- 皮肤病学 皮肤病学
- 肝病学 肝病学是一种肝病学.
- 临床药理学 临床药理学
背景情况:
- 史蒂文斯-约翰逊综合征 (SJS) 是一种严重的,罕见的粘膜皮肤反应,死亡率高.
- SJS呈现出水泡状的皮肤病变,发烧和全身毒性,可能导致严重的并发症,如器官衰竭.
研究的目的:
- 在慢性急性肝衰竭患者中报告药物诱导的SJS病例.
- 在先前存在的肝病的背景下讨论SJS的管理和结果.
主要方法:
- 一名51岁的女性患有不补偿的乙型肝炎肝硬化,在服用奥梅普拉后发生了SJS.
- 治疗包括停止疑似药物甲基prednisolone,并提供支持性护理.
主要成果:
- 患者经历了皮疹的消失和治疗后肝脏和功能显著改善.
- 这一案例突显了SJS在患有复杂肝衰竭的患者中成功管理的情况.
结论:
- 药物诱导的SJS可以发生在患有慢性急性肝衰竭的患者中,可能因免疫异常而加剧.
- 在这种情况下,有效的管理,包括药物戒断和皮质类固醇治疗,可以改善结果.
- 这个案例有助于了解严重肝病患者的SJS,帮助未来的治疗策略.
相关概念视频
Acid Suppressive Drugs for Peptic Ulcer Disease: Proton Pump Inhibitors
361
Peptic ulcers, often induced by H. pylori infections or NSAID usage, arise from disruptions in the delicate balance of gastric acid production. Peptic ulcers stem from heightened gastric acid levels due to H. pylori infections or NSAID use. The protective mucus layer diminishes in the presence of these factors, allowing gastric acid to erode the stomach lining and form ulcers.
Gastric acid, a potent cocktail of hydrogen and chloride ions, is produced in specialized parietal cells within the...
Gastric acid, a potent cocktail of hydrogen and chloride ions, is produced in specialized parietal cells within the...
361
Acid Suppressive Drugs for Peptic Ulcer Disease: Histamine H2-Receptor Antagonists
410
Histamine H2 receptors, which are intricately located on the basolateral membrane of parietal cells, play a crucial role in modulating gastric acid secretion. When released from enterochromaffin-like cells, histamine engages H2 receptors, initiating the cyclic AMP (cAMP) pathway. In this pathway, adenylyl cyclase converts ATP into cAMP, elevating intracellular cAMP levels. The activation of protein kinase A follows, stimulating the proton pump. This stimulation prompts the secretion of hydrogen...
410
Acid Suppressive Drugs for Peptic Ulcer Disease: Antacids
334
In the complex environment of the gastric lumen, excessive acid secretion can lead to the formation or worsening of ulcers within the delicate mucosal layer. Antacids, such as sodium bicarbonate and calcium carbonate, provide relief by neutralizing this acid, transforming it into harmless salt and water. This neutralization process raises the gastric pH from a highly acidic level of 1 to a more basic 3-4, reducing the acidity within the stomach.
However, this neutralization reaction between...
However, this neutralization reaction between...
334
Drugs for Peptic Ulcer Disease: Sucralfate as Mucosal Protective Agents
415
In the intricate landscape of the gastric lumen, excessive acid secretion disrupts the natural defense mechanisms, weakening the mucus-bicarbonate barrier. This vulnerability allows pepsin to infiltrate epithelial cells, digesting mucosal proteins and triggering erosion, leading to ulcer formation.
In this scenario, mucosal protective agents like sucralfate play an essential role. Sucralfate, a complex of sulfated sucrose and aluminum hydroxide, demonstrates its usefulness in acidic conditions,...
In this scenario, mucosal protective agents like sucralfate play an essential role. Sucralfate, a complex of sulfated sucrose and aluminum hydroxide, demonstrates its usefulness in acidic conditions,...
415
Peptic Ulcer Disease IV: Management
75
Medical treatment strategies for peptic ulcers encompass various methods. The primary goal of treatment is to diminish gastric acidity and strengthen mucosal defense mechanisms.
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
75
Barrett Esophagus-II: Clinical Manifestations and Management
122
Individuals with Barrett's esophagus are often asymptomatic, but they may experience symptoms commonly associated with GERD, such as heartburn and acid regurgitation. Additional symptoms can include difficulty swallowing, chest pain, unintentional weight loss, blood in the stool (which may appear black, tarry, or bloody), and episodes of vomiting.
To diagnose Barrett's esophagus, healthcare providers often recommend an endoscopy for those showing symptoms of acid reflux. The procedure...
To diagnose Barrett's esophagus, healthcare providers often recommend an endoscopy for those showing symptoms of acid reflux. The procedure...
122


